(10-133) Sodium-Glucose Cotransport 2 Inhibitors (SGLT-2i) and Heart failure: Impact on 30-day Readmission through a Pharmacist-Led Quality Improvement Initiative
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: UChicago Medicine AdventHealth Bolingbrook Residency Program Type: PGY1 (Community-Based Pharmacy) Residency Program Location: Illinois
